Integrated Scientific Advice: Helping to Optimize RWE Planning for Market Access
November 1st 2019A review of the current use of real-world data and evidence in HTA and payer appraisals, its potential role in lifecycle management, and how the early dialogue provided by Integrated Scientific Advice engagement can be used as a key tool in the planning and generation of RWE.
When Accessing Healthcare Value is in the Eye of the Beholder
September 3rd 2019As patients pay more healthcare expenses directly from their own pockets, the industry must look at patients' ability to pay alongside willingness to pay to understand the various factors of patient decisions to accept or decline treatment.